Torrent Pharmaceuticals is acquiring Curatio Healthcare for Rs 2,000 crore, which will catapult the Ahmedabad-based firm to the top league in the dermatology segment.

Curatio has a strong presence in the cosmetic dermatology segment with a portfolio of over 50 brands in the country. Its portfolio consists of brands such as Tedibar, Atogla, Spoo, B4 Nappi, and Permite, which are ranked amongst the top five brands in their covered market.

The top 10 brands of the company account for roughly 75 per cent of total revenues. Apart from these brands, Torrent Pharma will add a field force of 600 representatives and a distribution network of 900 stockists. Curatio posted revenues of Rs 224 crore in 2021-22.

Torrent Pharma said in a regulatory filing that it is acquiring 100 per cent of Curatio and the consideration includes Rs 115 crore (on the date of signing) of cash, and cash equivalents in the acquired business indicating an enterprise value of Rs 1,885 crore.